Company News for December 23, 2009 - Corporate Summary
• Micron Technology (NYSE:MU) posted fiscal first quarter earnings of 23 cents a share, up from estimates of 6 cents, on revenues of $1.74 billion, which beat consensus projections of $1.59 billion
• Cintas (NASDAQ:CTAS) reported non-GAAP earnings fell 21% to 39 cents, four cents under projections, as revenues dropped 10% from last year to $884.5 million
• Red Hat (NYSE:RHT) posted third quarter adjusted earnings of 17 cents a share, one penny above estimates, on better-than-expected revenues of $194.3 million, ahead of Street estimates of $188.49 million. Subscription revenues increased 21% to $164.4 million.
• Berkshire Hathaway (NYSE:BRK.A) reported a sale of 87,999 shares of Moody's Investor Services (NYSE:MCO) on December 18 for $26.77 apiece, selling shares of the firm for the sixth time since July
• Goldman Sachs (NYSE:GS) upgraded shares of Harmony Gold Mining (NYSE:HMY) to "buy" from "neutral," while initiating coverage of South Africa-based Gold Fields (NYSE:GFI) with a "buy" rating
• AIG International (NYSE:AIG) shares gained 10.7% on reports it has cancelled a planned IPO of its property-casualty unit Chartis, choosing instead to expand the business.
• Shares in YRC Worldwide (NASDAQ:YRCW) jumped 28.1% on news the company is ready to proceed with a new debt-for-equity exchange offer as the firm attempts to issue up to 42 million common shares to avoid bankruptcy filing
• TD Ameritrade (NASDAQ:AMTD) rose 4.1% after KBW upgraded the shares to "outperform" from "market perform," with a price target of $22.50
• Bristol-Myers Squibb (NYSE:BMY) said it plans to increase its dividend by 3.2% in the first quarter of 2010
• ConAgra (NYSE:CAG) shares gained 4.3% on a Credit Suisse (NYSE:CS) analyst note, which said strong cash flow could result in the announcement of a $660 million share repurchase, boosting earnings by 6%
• Schlumberger (NYSE:SLB) was upgraded by Barclays (NYSE:BCS) to "overweight" with a price target $73, up from $64
The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
